Qichao Zhou

Manteia is committed to deep learning, data technology, and traditional algorithm research in the field of tumor radiotherapy. Manteia is headquartered in Xiamen, China, it has a wholly-owned subsidiary in the United States. It is a foreign-introduced "Double Hundred Talents" enterprise by Xiamen Municipal Government and a strategicinvestment enterprise in the field of radiotherapy by Fosun Group and Danlu Capital.The company has R&D teams in China and the United States, with about 50 algorithms and engineers, of which 40% are doctors and 30% are masters. The core R&D personnel have published more than 170 SCI-indexed documents in the field of radiotherapy. It has 26 software copyrights, 2 international patents and 6 domestic patents.